Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Konstantin Slavin

Neurological Surgery Chicago, IL Medical Doctor

NPI 1407803166 CMS profile 198995

1740 W Taylor St, Chicago, IL 60612

Open in the dashboard

General payments

$152,915

179 records reported · program years 2019–2025

Research payments

$128

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$105,222 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Konstantin Slavin of Chicago, IL is reported in the CMS Open Payments database as having received $152,915 across 179 general payments and $128 in research payments paid to them. Separately, studies naming them as principal investigator received $105,222 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $46,112 41
2024 General $13,850 29
2023 General $16,577 14
2022 General $7,063 30
2021 General $11,226 17
2020 General $14,821 13
2019 General $43,266 35
2019 Research $128 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Konstantin Slavin
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Konstantin Slavin were reported at $46,112. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Konstantin Slavin Neurological Surgery median Middle half National median
2019 $43,266 $582 $138–$3,006 $163
2020 $14,821 $294 $76–$2,174 $114
2021 $11,226 $387 $105–$2,432 $132
2022 $7,063 $542 $139–$2,989 $149
2023 $16,577 $534 $145–$2,697 $160
2024 $13,850 $574 $155–$3,046 $164
2025 $46,112 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Biotronik Inc. $30,133 15 payments
  2. Abbott Laboratories $29,426 56 payments
  3. Ethicon US, LLC $21,737 3 payments
  4. Curonix LLC $16,887 7 payments
  5. Siemens Medical Solutions USA, Inc. $12,011 5 payments
  6. Saluda Medical Americas, Inc. $11,203 8 payments
  7. Medtronic USA, Inc. $8,942 10 payments
  8. Stryker Corporation $6,213 13 payments
  9. Integer Holdings Corporation $5,250 2 payments
  10. BIOTRONIK NRO, Inc. $2,230 12 payments
  11. Other $8,882 48 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $132,207 51 payments
  2. Travel and Lodging $10,464 32 payments
  3. Food and Beverage $6,693 93 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,308 2 payments
  5. Grant $242 1 payment
Products named General payments · program years 2019–2025
  1. SURGICEL NU-KNIT $21,737 3 payments
  2. VISTASEAL $21,588 2 payments
  3. ETHICON $21,588 2 payments
  4. SURGIFLO Hemostatic Matrix $21,588 2 payments
  5. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $16,887 7 payments
  6. Evoke $8,953 6 payments
  7. Proclaim Family of SCS IPGs $7,554 3 payments
  8. PROCLAIM $5,799 16 payments
  9. Infinity DBS Pulse Generators $5,607 3 payments
  10. Proclaim IPG $5,234 4 payments
  11. Other $16,717 101 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Saluda Medical Americas, Inc. $128 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Neurosurgery: 83

Drug cost

$388

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 15 $388

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$39,310

Medicare's payments for the services billed

Medicare patients

92

Average age 67

Services billed

174

50 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 65%
Depression 46%
Diabetes 33%
Chronic kidney disease 22%
COPD 22%
Ischemic heart disease 20%
Osteoporosis 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record